SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-065200
Filing Date
2023-11-20
Accepted
2023-11-20 17:28:46
Documents
81
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bxrx-20230930.htm   iXBRL 10-Q 2558153
2 EX-31.1 bxrx-ex31_1.htm EX-31.1 9935
3 EX-31.2 bxrx-ex31_2.htm EX-31.2 10308
4 EX-32.1 bxrx-ex32_1.htm EX-32.1 7386
  Complete submission text file 0000950170-23-065200.txt   12894235

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bxrx-20230930_cal.xml EX-101.CAL 62954
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bxrx-20230930_def.xml EX-101.DEF 400271
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bxrx-20230930_pre.xml EX-101.PRE 584475
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bxrx-20230930_lab.xml EX-101.LAB 800940
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bxrx-20230930.xsd EX-101.SCH 105702
75 EXTRACTED XBRL INSTANCE DOCUMENT bxrx-20230930_htm.xml XML 2381546
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39101 | Film No.: 231423738
SIC: 2834 Pharmaceutical Preparations